Mark R. Albertella

2.8k citations
34 papers · 1.0k indexed · h-index 13
Topics
DNA Repair Mechanisms (8 papers)PARP inhibition in cancer therapy (7 papers)RNA modifications and cancer (6 papers)

In The Last Decade

Mark R. Albertella

33 papers receiving 1.0k citations

Peers

Mark R. Albertella
Comparison fields: 5 of 78
  • Molecular Biology 766
  • Cancer Research 351
  • Oncology 256
  • Cell Biology 147
  • Immunology 97
Replace Yen-An Tang with:
Yen-An Tang Taiwan
Martina Bazzaro United States
Corey Lourenco Canada
Reza Beheshti Zavareh United States
Yari Ciani Italy
Kathleen A. Scorsone United States
Yiyu Dong United States
Takehisa Matsumoto Japan
Vladimir Khazak United States
Nicolas Floc’h United Kingdom
Mark R. Albertella relative to Yen-An Tang Taiwan Yen-An Tang's profile →
Citations per field
00.5×1.5×2.1×
Yen-An Tang · 1×
Citations per year

Countries citing papers authored by Mark R. Albertella

Since Specialization
Citations

This map shows the geographic impact of Mark R. Albertella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Albertella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Albertella more than expected).

Fields of papers citing papers by Mark R. Albertella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Albertella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Albertella. The network helps show where Mark R. Albertella may publish in the future.

Co-authorship network of co-authors of Mark R. Albertella

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Albertella. A scholar is included among the top collaborators of Mark R. Albertella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Albertella. Mark R. Albertella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 9
5 1
6 90
7 3
8 17
9 2
10 39
11 23
12 98
13
Identification of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors using a small-molecule library approach [abstract]
3
14
In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts
6
15
The novel hypoxia-targeted anticancer agent AQ4N is not subject to multi-drug resistance mediated by PGP/MDR1
1
16 211
17 12
18 3
19 24
20 53

About Mark R. Albertella

Mark R. Albertella is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), PARP inhibition in cancer therapy (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (351 citations), Molecular Biology (766 citations) and Oncology (256 citations). Mark R. Albertella has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Mark J. O’Connor, Alan Lau, Alan R. Lehmann, Catherine Green, Anthony Tighe, Stephen S. Taylor, Victoria Johnson, Alvin Wong, Alshad S. Lalani and Paul M. Loadman. Their work appears in journals such as Journal of Clinical Oncology, Genes & Development and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026